Dr. Elizabeth Hale Hammond is Professor of Pathology and Adjunct Professor of Internal Medicine at the University of Utah School of Medicine. She is past chairman of the pathology department at LDS Hospital and currently a member of Intermountain Healthcare Board of Trustees. She is internationally known as a researcher, educator, and expert in transplantation pathology and in predictive cancer factor evaluation.
The bulk of her research has been performed within the UTAH Cardiac Transplant Program and in the emerging field of predictive cancer factor testing. Her leadership efforts and published findings have led to standardized laboratory testing procedures now used throughout the United States, including diagnosis of cardiac transplant rejection, HER2 testing in breast cancer, and summary cancer reports.
Dr. Hammond is the author of 3 books, 15 book chapters, and 165 papers in peer-reviewed medical journals. She was recently recognized by the College of American Pathologists as the 2005 Pathologist of the Year "for outstanding leadership to the field of pathology and for pathologists, to the programs of the College, and for continued advocacy through her life work dedicated to improving the lives of patients."
Affiliations: Professor of Pathology, Adjunct Professor of Internal Medicine (Cardiology), University of Utah School of Medicine, Salt Lake City, UT; Consultant Pathologist and member of the Board of Trustees, Intermountain Healthcare Amirsys Publications: